A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Rilinger J 

PROVIDER: S-EPMC7267747 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature